Quantcast

Latest Chemokine Stories

2008-08-06 09:00:11

Chemokine Therapeutics Corp. ("Chemokine Therapeutics" or the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular disease today announced that research results were presented yesterday by the laboratory of Dr. Danny R. Welch, President of the Metastasis Research Society and Professor of Pathology, Cell Biology and Pharmacology, University of Alabama at Birmingham, at the Joint Metastasis Research...

78eba79291bd4015b7fdd923b80f4c471
2008-07-17 16:35:00

New research has found that a gene variant may make Africans more vulnerable to HIV infection, while also helping them live longer once infected. The genetic variation originated thousands of years ago to protect Africans from malaria, the researchers said Wednesday. The gene involved in the study controls a surface protein on red blood cells. Those with the genetic variation were found to have a 40 percent higher risk of becoming infected with HIV, researchers in the United States and...

2008-07-10 09:00:14

Compugen has announced positive results from a recently completed in vivo study of CGEN-25007, a novel peptide antagonist of the gp96 protein. Using an animal model of endotoxemia, a condition in which there is a substantial increase in the levels of inflammatory cytokines and chemokines in serum, CGEN-25007 was shown to exhibit a profound and dose-dependent anti-inflammatory activity. In this study, the novel peptide was administered following the introduction of lipopolysaccharide (LPS),...

2008-07-09 09:01:02

Compugen Ltd. (NASDAQ:CGEN) announced today positive results from a recently completed in vivo study of CGEN-25007, a novel peptide antagonist of the gp96 protein. The data indicate that CGEN-25007 has immunosuppressive effects and therapeutic potential for the treatment of various inflammatory diseases and other immune related pathologies. CGEN-25007, which has been shown to bind to recombinant gp96 in a dose dependent manner, was initially predicted using the Company's previously announced...

2008-07-02 09:00:14

Chemokine Therapeutics Corp. (the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced that it has been granted U.S. Patent No. 7,378,098. Patent No. 7,378,098 entitled "CXC Chemokine Receptor 4 Agonist Peptides" is related to treatment of patients in need of bone marrow or stem cell transplantation. This patent is based on evidence that treatment with SDF-1 chemokine analog...

2008-06-30 09:03:37

RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by treatment with zinc finger DNA-binding protein nucleases (ZFN(TM)). The data suggest that the ZFN approach, which results in the permanent modification of the CCR5 gene encoding an important receptor for HIV infection, is a promising strategy for the treatment of HIV/AIDS....

2008-03-27 09:34:35

A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California. The method can also be used to study how migration of cancer cells and nerves can be controlled. These interesting findings have now been published in the Journal of Biological Chemistry.Formation of new blood cells and lymph vessels takes place with a number of different diseases....

15d41ea18e8053147c3f8174856b09141
2007-03-28 16:11:42

A new Vanderbilt University study has identified a chemical signal that plays a critical role in forming the heart, which could lead to new strategies to combat congenital heart defects. In the initial stage of development, called gastrulation, the fertilized egg undergoes a marvelous and complex transformation from a ball of identical cells into an embryo with a distinct shape and a number of different cell types. During this transformation, cells move to specific locations where they begin...

2005-06-22 13:00:00

Physicians might one day be able to treat a disease that destroys brain cells in children using genetically modified cells to transport a "drug" to the site of the dying neural cells (cells that transmit impulses). This discovery occurred based on results of a laboratory study of the technique published by investigators at St. Jude Children's Research Hospital. A report on this work appears in the prepublication online issue of Blood. There is currently no cure for such disorders, which are...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.